CONTEXT: At advanced stages, cancer, congestive heart failure (CHF), and chronic obstructive pulmonary disease (COPD) produce high rates of hospitalization, disability, and annual mortality. Despite similar prognoses, patients with cancer often are treated differently than those with other illnesses, the former being seen as terminal vs. chronic. OBJECTIVES: The purpose of this study was to compare the functional capacity, emotional well-being, and quality of life of patients in three disease groups to assess whether diagnosis distinguishes differences in patient experience, and compare patients with cancer and noncancer diagnoses. METHODS: Baseline data from a cohort study of 210 patients who had an estimated 50% two-year mortality were analyzed. The patients had Stage IV breast, prostate, or colon cancer; Stage IIIb or IV lung cancer; New York Heart Association Stage III or IV CHF with a left ventricular ejection fraction of <40%; or COPD with hypercapnea (pC02>46) and at least one hospitalization or Emergency Department visit during the past year. Measures included the Rosow-Breslau Activities of Daily Living/Instrumental Activities of Daily Living tool, Profile of Mood States anxiety subscale, brief Centers for Epidemiologic Studies Depression Scale, and the Functional Assessment of Cancer Therapy-General quality-of-life instrument. Analyses included descriptive statistics, analysis of variance, and adjusted linear regression models. RESULTS: A majority of illness outcomes did not differ by diagnostic category. Functional status was associated with diagnosis, with CHF and COPD patients faring worse than those with cancer. Overall, illness experience was most significantly related to disease severity, demographics, and emotional and social well-being. CONCLUSION: Comparing patients with advanced cancer, CHF, and COPD, illness experience was more similar than different. Patients living with life-limiting illnesses other than cancer may benefit from whole-person services often extended to cancer patients.
CONTEXT: At advanced stages, cancer, congestive heart failure (CHF), and chronic obstructive pulmonary disease (COPD) produce high rates of hospitalization, disability, and annual mortality. Despite similar prognoses, patients with cancer often are treated differently than those with other illnesses, the former being seen as terminal vs. chronic. OBJECTIVES: The purpose of this study was to compare the functional capacity, emotional well-being, and quality of life of patients in three disease groups to assess whether diagnosis distinguishes differences in patient experience, and compare patients with cancer and noncancer diagnoses. METHODS: Baseline data from a cohort study of 210 patients who had an estimated 50% two-year mortality were analyzed. The patients had Stage IV breast, prostate, or colon cancer; Stage IIIb or IV lung cancer; New York Heart Association Stage III or IV CHF with a left ventricular ejection fraction of <40%; or COPD with hypercapnea (pC02>46) and at least one hospitalization or Emergency Department visit during the past year. Measures included the Rosow-Breslau Activities of Daily Living/Instrumental Activities of Daily Living tool, Profile of Mood States anxiety subscale, brief Centers for Epidemiologic Studies Depression Scale, and the Functional Assessment of Cancer Therapy-General quality-of-life instrument. Analyses included descriptive statistics, analysis of variance, and adjusted linear regression models. RESULTS: A majority of illness outcomes did not differ by diagnostic category. Functional status was associated with diagnosis, with CHF and COPDpatients faring worse than those with cancer. Overall, illness experience was most significantly related to disease severity, demographics, and emotional and social well-being. CONCLUSION: Comparing patients with advanced cancer, CHF, and COPD, illness experience was more similar than different. Patients living with life-limiting illnesses other than cancer may benefit from whole-person services often extended to cancerpatients.
Authors: Terri R Fried; Amy L Byers; William T Gallo; Peter H Van Ness; Virginia R Towle; John R O'Leary; Joel A Dubin Journal: Arch Intern Med Date: 2006-04-24
Authors: Donald H Taylor; Karen Steinhauser; James A Tulsky; John Rattliff; Courtney Harold Van Houtven Journal: Am J Hosp Palliat Care Date: 2008-01-15 Impact factor: 2.500
Authors: Karen E Steinhauser; Elizabeth C Clipp; Judith C Hays; Maren Olsen; Robert Arnold; Nicholas A Christakis; Jennifer Hoff Lindquist; James A Tulsky Journal: Palliat Med Date: 2006-12 Impact factor: 4.762
Authors: David Casarett; Jessica Fishman; Peter J O'Dwyer; Frances K Barg; Mary Naylor; David A Asch Journal: J Clin Oncol Date: 2008-03-10 Impact factor: 44.544
Authors: Allison M Burton; Jessica M Sautter; James A Tulsky; Jennifer Hoff Lindquist; Judith C Hays; Maren K Olsen; Sheryl I Zimmerman; Karen E Steinhauser Journal: J Pain Symptom Manage Date: 2012-06-22 Impact factor: 3.612
Authors: Megan Bannon; Natalie C Ernecoff; J Nicholas Dionne-Odom; Camilla Zimmermann; Jennifer Corbelli; Michele Klein-Fedyshin; Robert M Arnold; Yael Schenker; Dio Kavalieratos Journal: J Palliat Med Date: 2019-02-14 Impact factor: 2.947
Authors: Laura P Gelfman; Dio Kavalieratos; Winifred G Teuteberg; Anuradha Lala; Nathan E Goldstein Journal: Heart Fail Rev Date: 2017-09 Impact factor: 4.214
Authors: Dio Kavalieratos; Arif H Kamal; Amy P Abernethy; Andrea K Biddle; Timothy S Carey; Sandesh Dev; Bryce B Reeve; Morris Weinberger Journal: J Palliat Med Date: 2014-03-03 Impact factor: 2.947
Authors: Jessica M Sautter; James A Tulsky; Kimberly S Johnson; Maren K Olsen; Allison M Burton-Chase; Jennifer Hoff Lindquist; Sheryl Zimmerman; Karen E Steinhauser Journal: J Am Geriatr Soc Date: 2014-05-06 Impact factor: 5.562
Authors: Katherine R Courtright; Vanessa Madden; Nicole B Gabler; Elizabeth Cooney; Dylan S Small; Andrea Troxel; David Casarett; Mary Ersek; J Brian Cassel; Lauren Hersch Nicholas; Gabriel Escobar; Sarah H Hill; Dan O'Brien; Mark Vogel; Scott D Halpern Journal: Ann Am Thorac Soc Date: 2016-09